Form 4 for TRLV Trulieve Cannabis Corp.
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-13 · accession 0002107378-26-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-17 | 2026-03-13 | TRLV | Hersey Christine Ann | Chief Corp Affairs, Strategy | A - Grant | $0.00 | +58.6K | 143.8K | +69% | $0 |
| D | 2026-03-17 | 2026-03-13 | TRLV | Hersey Christine Ann | Chief Corp Affairs, Strategy | A - Grant | $0.00 | +41.7K | 41.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Subordinate Voting Shares | 2026-03-13 | A | A | 58,594 | $0.00 | 143,767 | D | — | — | (F1) Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. ("Trulieve") subordinate voting share. 50% of the RSUs will vest on December 1, 2027, and the remaining 50% of the RSUs will vest on December 1, 2028. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-03-13 | A | A | 41,668 | $0.00 | 41,668 | D | $6.40 · — to 2033-03-13 | 41,668 Subordinate Voting Shares | (F2) The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2026, one-third vesting on December 1, 2027, and one-third vesting on December 1, 2028. |